Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -301.80x is 81% above its 3-year average of -1581.15x, near the high end of its 3-year range (-3498.00x–-28.81x).
As of the fiscal period ended Saturday, December 31, 2022. 78.43% above its 12-month average of -1398.90x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2022 (2022-12-31): -301.80x.
INTEREST COVERAGE RATIO
-301.80x
INTEREST COVERAGE RATIO AVG TTM
-1398.90x
INTEREST COVERAGE RATIO AVG 3Y
-2098.60x
INTEREST COVERAGE RATIO AVG 5Y
-1581.15x
INTEREST COVERAGE RATIO AVG 10Y
-1266.41x
INTEREST COVERAGE RATIO AVG 15Y
-112.60x
INTEREST COVERAGE RATIO AVG 20Y
-105.43x
CURRENT VS TTM AVG
+78.43%
CURRENT VS 3Y AVG
+85.62%
CURRENT VS 5Y AVG
+80.91%
CURRENT VS 10Y AVG
+76.17%
CURRENT VS 15Y AVG
-168.03%
CURRENT VS 20Y AVG
-186.26%
SECTOR MEDIAN · HEALTHCARE
-5.42x
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
-5468.27%
vs the sector median at left
BioCardia, Inc.
Market Cap
$16.08M
Interest Coverage Ratio
-301.80x
TTM Avg
-1398.90x
3Y Avg
-2098.60x
5Y Avg
-1581.15x
Market Cap
$16.81M
Interest Coverage Ratio
-111.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.58M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
Market Cap
$15.83M
Interest Coverage Ratio
-68.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.81M
Interest Coverage Ratio
-1288.77x
TTM Avg
51.73x
3Y Avg
51.73x
5Y Avg
51.73x
Market Cap
$15.58M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.09M
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$17.19M
Interest Coverage Ratio
N/A
TTM Avg
15.47x
3Y Avg
15.47x
5Y Avg
15.47x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCardia, Inc. (BCDA) | $16.08M | -301.80x | -1398.90x | -2098.60x | -1581.15x |
| Bionano Genomics, Inc. (BNGO)vs › | $16.81M | -111.88x | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.58M | -15.67x | 0.81x | 0.81x | 0.81x |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.83M | -68.14x | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.81M | -1288.77x | 51.73x | 51.73x | 51.73x |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.58M | N/A | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.09M | N/A | 1.00x | 1.00x | 1.00x |
| Lipocine Inc. (LPCN)vs › | $17.19M | N/A | 15.47x | 15.47x | 15.47x |
| PAVmed Inc. (PAVM)vs › | $17.55M | -1038.38x | N/A | N/A | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.15M | N/A | N/A | N/A | N/A |
Interest Coverage
-301.8x
Debt/Equity
0.11
Current Ratio
2.09
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-12-31 | -301.80x |
| 2022-06-30 | -2496.00x |
| 2020-12-31 | -3498.00x |
| 2019-09-30 | -28.81x |
| 2016-12-31 | -7.45x |
| 2011-12-31 | -52.67x |
| 2011-09-30 | -22.00x |
| 2011-03-31 | -4.21x |
| 2010-12-31 | 2099.80x |
| 2010-03-31 | -208.86x |
| 2009-12-31 | -656.00x |
| 2009-09-30 | -201.83x |
| 2009-06-30 | -168.38x |
| 2009-03-31 | -154.00x |
| 2008-09-30 | -88.57x |
| 2003-12-31 | -26.58x |
